Immix Biopharma Inc. Gains 25.38%
Thu, May 19, 2022 at 05:30 PM
Immix Biopharma Inc. (IMMX:NASDAQ) soared at $1.63, representing a gain of 25.4%. On Wed, May 18, 2022, IMMX:NASDAQ touched a New 2-Week Low of $1.3. The stock got featured on our News Catalysts scanner on Mon, May 09, 2022 at 08:43 AM in the 'ACQUISITION' category. From Thu, May 05, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Mon, Jan 03, 2022 at $8.68 with a volume of 148M+, and its share price has been moving sideways in recent weeks.
About Immix Biopharma Inc. (IMMX:NASDAQ)
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Top 10 Gainers:
- NeuroMetrix, Inc. (NURO:NASDAQ), 76.28%
- VivoPower International PLC (VVPR:NASDAQ), 46.3%
- BIT Mining Limited ADS (BTCM:NYSE), 28.05%
- AcelRx Pharmaceuticals, Inc. (ACRX:NASDAQ), 27.63%
- Pop Culture Group Co. Ltd (CPOP:NASDAQ), 27.59%
- Immix Biopharma Inc. (IMMX:NASDAQ), 25.38%
- JE Cleantech Holdings Limited (JCSE:NASDAQ), 25%
- Celyad SA (CYAD:NASDAQ), 25%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 24.2%